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Fig 1. Primary cutaneous nocardiosis left infraorbital
ulceration.
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immunocompetent host following laser
resurfacing
To the Editor: A 66-year-old immunocompetent
woman presented with a 3-month history of a
nonhealing left infraorbital ulcer. The lesion began
as a pustule following erbium:YAG laser resurfacing
performed to improve cosmesis after an upper and
lower blepharoplasty. Over several weeks the lesion
evolved into a shallow, nonhealing ulceration.
Initially, the patient was treated with minocycline,
cephalexin, and topical mupirocin without improve-
ment. On presentation to our dermatology clinic, the
patient was being treatedwith oral prednisone 60mg
daily, topical desoximetasone 0.25% ointment, and
valacyclovir 1000 mg twice daily.
On physical examination, a 1.4-cm oval shallow
ulceration without purulence or exudate was noted
on the left infraorbital rim (Fig 1). Skin biopsy
revealed ulceration with a mixed inflammatory
infiltrate. Gram stain demonstrated gram-positive,
focally branching, bacilli (Fig 2). Periodic
acideSchiff and acid-fast bacilli stains were negative;
however, mycobacterium tuberculosis polyclonal
antibody stain (Biocare Medical PP140AA) showed
dot-like positivity. No evidence of herpes viral
change was noted.
On follow-up, prednisone was gradually discon-
tinued and minocycline was started for presumed
Open access under CC BY-NC-ND license.atypical mycobacterial infection. Another biopsywas
obtained for bacterial, fungal, and mycobacterial
culture. The receiving microbiology lab was notified
in advance of the possibility of atypical mycobacteria
and Nocardia species. Bacterial cultures were
initially reported as normal skin flora. The microbi-
ology laboratory was asked to specifically look for
Nocardia. Several days later, Nocardia asteroides
complex was isolated. Fungal and mycobacterial
cultures were negative at 6 weeks. Trimethoprim-
sulfamethoxazole DS 3 times daily was initiated and
the patient was referred to an infectious disease
physician for a workup to identify potential sources
of infection. The workup included magnetic reso-
nance imaging of the brain, as well as computed
tomography examination of the chest; no systemic
source of infection was identified. Marked improve-
ment was noted at 2 weeks (Fig 2), although a mild
ectropion developed at 3 months.
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mentous, partially acid-fast bacilli Nocardia, which
includes more than 50 ubiquitous, slow growing
aerobic species.1 Approximately 500 to 1000 cases of
nocardiosis occur in the United States per year.2
Primary cutaneous nocardiosis, most often caused by
Nocardia brasiliensis, typically affects immunocom-
petent individuals with a history of trauma and is
grouped into three entities: lymphocutaneous infec-
tion, mycetoma, and superficial skin infection
including ulceration, abscess, and cellulitis. N aster-
oides complex typically causes skin infection from
hematogenous dissemination from a pulmonary
focus and is frequently associated with systemic
disease.3 Treatment should include evaluation
for systemic disease as well as a minimum of 6
weeks of antibiotic therapy with trimethoprim-
sulfamethoxazole, the treatment of choice for no-
cardiosis; treatment may be needed for up to 1 year.
Given the difficulty in isolating Nocardia spp, it is
crucial to notify the laboratory if nocardiosis is
suspected so that the appropriate time (3 to 21
days) and growth conditions are provided.1,3,4 As
demonstrated in this case, it is imperative for the
clinician to follow up on abnormal or unexpected
results, and to contact the laboratory and other
involved physicians. Dermatologists must be aware
of this potentially difficult to diagnose organism as a
potential cause of nonhealing ulceration and other
cutaneous infections.
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setting of autoimmune disease
To the Editor: An unusual presentation of Sweet
syndrome, giant cellulitis-like type, has recently
been reported in the setting of malignancy and
morbid obesity.1 We report a case of giant
cellulitis-like Sweet syndrome in a patient with
autoimmune disease in the absence of malignancy.
A 54-year-old woman with history of sicca
syndrome, recurrent primary biliary cirrhosis (PBC)
despite a liver transplant for PBC 16 years previously,
and morbid obesity presented with a new red rash of
at least 3 days’ duration. Shewas initially hospitalized
for Escherichia coli bacteremia (1 month before rash
onset) that was treated with intravenous cefepime
for 2 weeks; subsequent bacterial blood cultures
were negative. Despite successful eradication of the
bacteremia, chills and fevers associated with the new
rash developed. Initially the rash was treated as
cellulitis but did not respond to treatment with
intravenous vancomycin.
On examination (Fig 1), there weremultiple large,
scattered, erythematous, edematous, indurated
papules and confluent plaques on her buttocks,
extremities, and trunk; the eruption progressed to
involve the head and neck. Punch biopsies of a
papule and plaque on the patient’s back
revealed prominent papillary dermal edema with a
mixed inflammatory cell infiltrate composed of
abundant neutrophils intermixed with lymphocytes,
histiocytes, and eosinophils (Fig 2), consistent with
Sweet syndrome. Leukocytoclastic vasculitis was
not noted. Serum blood counts and chemistry
demonstrated a normocytic anemia with hemo-
globin of 8.1 g/dL, normal white blood count of
4.1 K/L (with a slightly increased neutrophil count
of 77%), and increased creatinine of 1.7 mg/dL.
Tissue cultures for bacteria and fungi were negative.
The patient was treated with a prednisone taper over
a course of 40 days. The lesions improved rapidly
within 48 hours after initiation of treatment. Rare
clinical presentations of Sweet syndrome include
necrotizing fasciitis and cellulitic types,1-5 and do
not respond to antibiotics.3 Widespread ‘‘giant
cellulitis-like’’ Sweet syndrome, such as presented
in this case, was recently reported in 3 patients.1
All of the cases described obese patients
with recurrent fever and widespread infiltrated
